Pages that link to "Q37681007"
Jump to navigation
Jump to search
The following pages link to A niche-like culture system allowing the maintenance of primary human acute myeloid leukemia-initiating cells: a new tool to decipher their chemoresistance and self-renewal mechanisms (Q37681007):
Displaying 31 items.
- Hypoxia and Hypoxia-Inducible Factors in Leukemias (Q26767167) (← links)
- A hostel for the hostile: the bone marrow niche in hematologic neoplasms (Q26777629) (← links)
- Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies (Q34548815) (← links)
- Concise reviews: cancer stem cells: from concept to cure. (Q38235552) (← links)
- Integration of hypoxic HIF-α signaling in blood cancers (Q38769432) (← links)
- Myeloid malignancies and the microenvironment (Q39073878) (← links)
- Can systems biology approach help in finding more effective treatment for acute myeloid leukemia? (Q39191779) (← links)
- The hypoxia signalling pathway in haematological malignancies. (Q39246376) (← links)
- Long-term in vitro maintenance of clonal abundance and leukaemia-initiating potential in acute lymphoblastic leukaemia. (Q42041565) (← links)
- Mesenchymal Stem Cells Support Survival and Proliferation of Primary Human Acute Myeloid Leukemia Cells through Heterogeneous Molecular Mechanisms (Q42262053) (← links)
- The combination of CHK1 inhibitor with G-CSF overrides cytarabine resistance in human acute myeloid leukemia (Q44601913) (← links)
- Signaling mechanisms that regulate ex vivo survival of human acute myeloid leukemia initiating cells. (Q46140977) (← links)
- Mitochondrial Transfer in the Leukemia Microenvironment (Q46249283) (← links)
- Chemotherapy-Resistant Human Acute Myeloid Leukemia Cells Are Not Enriched for Leukemic Stem Cells but Require Oxidative Metabolism (Q46381905) (← links)
- Acute myeloid leukemia xenograft success prediction: Saving time (Q49662874) (← links)
- Role of the microenvironment in myeloid malignancies (Q49986947) (← links)
- Leukemia Stem Cells Microenvironment (Q50076185) (← links)
- Homoharringtonine (omacetaxine mepesuccinate) as an adjunct for FLT3-ITD acute myeloid leukemia. (Q51426321) (← links)
- Therapeutic targeting of leukemic stem cells in acute myeloid leukemia - the biological background for possible strategies (Q51818965) (← links)
- The chromatin-remodeling factor CHD4 is required for maintenance of childhood acute myeloid leukemia. (Q52431146) (← links)
- Alginate foam-based three-dimensional culture to investigate drug sensitivity in primary leukaemia cells. (Q52562901) (← links)
- Extracellular Vesicles: A New Prospective in Crosstalk between Microenvironment and Stem Cells in Hematological Malignancies. (Q55421956) (← links)
- The Oncogenic Transcription Factor RUNX1/ETO Corrupts Cell Cycle Regulation to Drive Leukemic Transformation (Q57293716) (← links)
- The Ins and Outs of Autophagy and Metabolism in Hematopoietic and Leukemic Stem Cells: Food for Thought (Q57491369) (← links)
- Hif-1α Deletion May Lead to Adverse Treatment Effect in a Mouse Model of MLL-AF9-Driven AML (Q60932672) (← links)
- Dexamethasone in hyperleukocytic acute myeloid leukemia (Q88007476) (← links)
- A novel method for detecting the cellular stemness state in normal and leukemic human hematopoietic cells can predict disease outcome and drug sensitivity (Q91297721) (← links)
- High Constitutive Cytokine Release by Primary Human Acute Myeloid Leukemia Cells Is Associated with a Specific Intercellular Communication Phenotype (Q91658483) (← links)
- Gap Junctions in the Bone Marrow Lympho-Hematopoietic Stem Cell Niche, Leukemia Progression, and Chemoresistance (Q93006776) (← links)
- Metabolic underpinnings of leukemia pathology and treatment (Q98154686) (← links)
- A trispecific killer engager molecule against CLEC12A effectively induces NK-cell mediated killing of AML cells (Q100958764) (← links)